PICU Doc On Call

PICU Management of Malignant Hyperthermia

Apr 14, 2024
Explore a case of Malignant Hyperthermia in a 23-month-old premature boy during surgery, discussing pathophysiology, clinical signs, symptoms, and management. Learn about Dantraline's role in inhibiting calcium release, clinical features of MH crisis, triggers, and potential complications. Understand differential diagnoses like Neuroleptic Malignant Syndrome and Serotonin Syndrome. Gain insights into managing MH crisis in pediatric patients, emphasizing the need for a coordinated team and pharmacist collaboration.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

OR Case: Rapid MH Presentation

  • A 23-month-old ex-28-week preemie developed rising ETCO2, tachycardia and fever near end of hernia repair after sevoflurane exposure.
  • The child arrived to PICU chemically paralyzed with rigidity, high lactate, metabolic acidosis and myoglobinuria suggesting malignant hyperthermia.
INSIGHT

Jaw Rigidity And Rising ETCO2 Are Early Clues

  • Early anesthetic signs are a tight clenched jaw and a rising end-tidal CO2 despite increased ventilation.
  • These signs often precede marked hyperthermia and should trigger immediate MH evaluation.
INSIGHT

RYR1 Defect Explains the Whole Cascade

  • MH results from defective RYR1 causing uncontrolled calcium release from the sarcoplasmic reticulum and sustained muscle contraction.
  • The hypermetabolic state raises CO2 and heat while consuming ATP, producing lactic acidosis and risking rhabdomyolysis and organ injury.
Get the Snipd Podcast app to discover more snips from this episode
Get the app